Latest Breaking News On - ஆண்ட்ரூ வில்லிஸ் - Page 5 : comparemela.com
Politics Briefing: Provinces set to unveil next stage of mass-vaccination campaigns
theglobeandmail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theglobeandmail.com Daily Mail and Mail on Sunday newspapers.
Mississauga battery recycler Li-Cycle files to go public on NYSE in US$1 7-billion deal
theglobeandmail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theglobeandmail.com Daily Mail and Mail on Sunday newspapers.
In this week’s podcast, we find opportunities in a lagging sector, Russ Kinnel offers ideas for an IRA, Ben Johnson unpacks a trend between mutual funds and ETFs, Andrew Willis shines a light on a virtual healthcare company, and Kristoffer Inton discusses uranium prices.
Subscribe to Investing Insights
Letters to the editor: Jan 29: Enough! We should be proud that Julie Payette is Canadian Readers react after Payette s office described as toxic, plus other letters to the editor
theglobeandmail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theglobeandmail.com Daily Mail and Mail on Sunday newspapers.
Link Copied
Editor’s note:Read the latest on how the coronavirus is rattling the markets and what investors can do to navigate it.
Andrew Willis: Some of the most successful stocks in the pandemic have soared as services went online. Zoom, Shopify, and Amazon solved our communications and consumer needs but what about our
health? Enter Teladoc (TDOC), a leading provider of virtual healthcare technology. The company provides online doctor consultations alongside a suite of software that offers ongoing care in fields like cardiology, diabetes, weight, and mental health management. Amidst a massive medical crisis, it’s surprising to see Teladoc still trading around our fair value estimates forgoing, so far, the same level of hype that we’ve seen inflate other pandemic-related stocks to unrealistic valuations.